Polarean Imaging (POLX)

Sector:

Health Care

Index:

FTSE AIM All-Share

1.55p
   
  • Change Today:
      0.025p
  • 52 Week High: 6.82
  • 52 Week Low: 1.18
  • Currency: UK Pounds
  • Shares Issued: 1,207.03m
  • Volume: 1,745,039
  • Market Cap: £18.71m
  • Beta: 1.66

POLX Overview

Polarean is a clinical-stage company with a core technology that is a drug-device combination product that enables the visualisation of hyperpolarised 129Xe ("HPX") using MRI technology to help diagnose lung disease earlier, identify the type of intervention likely to benefit a patient, and to monitor the efficacy of treatment. It is currently being used at a number of research sites on a pre-FDA clearance basis to facilitate the research and evaluation of lung function, to assist in making improved disease progression assessment and to clearly visualise the effectiveness of several therapeutics which are under development.

1 Day Chart (05-11-2024)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1409.2% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 27.3 n/a
Pr/Book 2.9  
Latest F'cast
Revenue -13.7% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

POLX Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 2.30 (6.10) (4.85)¢ n/a n/a n/a n/a 0.0%
31-Dec-20 1.06 (6.53) (3.75)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 1.19 (14.02) (6.06)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 1.03 (13.91) (5.63)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 0.89 (11.89) (4.69)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

POLX Company Announcements

Virtual investor day 25-Sep-2024 07:00 RNS
Half-year Report 04-Sep-2024 07:00 RNS
Appointment of Vice President of Sales 03-Sep-2024 07:00 RNS

Latest POLX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

POLX Market Data

Currency UK Pounds
Share Price 1.55p
Change Today 0.025p
% Change 1.64 %
52 Week High 6.82
52 Week Low 1.18
Volume 1,745,039
Shares Issued 1,207.03m
Market Cap £18.71m
Beta 1.66

POLX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average
Income Not Available
Growth
Market averageMarket averageMarket averageMarket averageMarket average
61.11% below the sector average61.11% below the sector average61.11% below the sector average61.11% below the sector average61.11% below the sector average

POLX Dividends

No dividends found

Trades for 05-Nov-2024

Time Volume / Share Price
16:22 250,000 @ 1.59p
15:58 5,812 @ 1.58p
15:34 67,269 @ 1.53p
13:07 14,650 @ 1.53p
12:34 500,000 @ 1.55p

POLX Key Personnel

CFO Charles Osborne
CEO Christopher von Jako

Top of Page